Lincoln Pharmaceuticals Q1, Q2, Q3, Q4, FY 2017-18, FY 2016-17 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Lincoln Pharmaceuticals Company Profile :

Lincoln Pharmaceuticals Limited is an Indian company engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Company offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products.

Company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others.


Lincoln Pharmaceuticals ResultsBSE Code : 531633
NSE Symbol : LINCOLN
ISIN No. : INE405C01035
Industry :  Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Lincoln Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Lincoln Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2017-18 Results of Lincoln Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2016-17 Results of Lincoln Pharmaceuticals.

Lincoln Pharmaceuticals Q1 Results 2016-17 :

Lincoln Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Lincoln Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

Lincoln Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

Lincoln Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

Lincoln Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Lincoln Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 317.10 407.51
Other Income  –  0.00
Total Income  317.10  407.51
Expenditure  -278.32  -364.48
Interest  -5.54  -9.96
Depreciation  -3.19  -4.84
PBT  30.06  33.06
Tax  -8.31  -9.26
Net Profit  21.75  23.80
Equity  16.31  16.31
EPS  13.01  14.52

Note : If you like this information about Lincoln Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.